• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
A regulator`s view of end of Phase II decision making and
A regulator`s view of end of Phase II decision making and

... “Treating the physicians” – sometimes referred to in cancer as well Problem – important adverse events difficult to distinguish from lack of efficacy e.g. suicidality, agitation ...
Cefakliman mono
Cefakliman mono

... If patients, suffering from estrogen-dependent tumours, are/were in medical care, Cefakliman® mono must not be used as it is not known if Cimicifuga rootstock extracts support estrogen-dependent tumours or if they do not have any influence. There has not been sufficient research for the application ...
A Rapid Instrumented Fluorescence Immunoassay for the
A Rapid Instrumented Fluorescence Immunoassay for the

... When a sample solution containing the analyte passes through the assay reagent in the micro column, the analyte displaces the tracer at the binding site of the antibody. The displacement of flourophore-labeled THC from the immobilized antibody by saliva specimens containing THC produces a fluorescen ...
Prescribing Information
Prescribing Information

... Avoid use during the third trimester of pregnancy because NSAIDs such as DURLAZA may cause premature closure of the fetal ductus arteriosus. Salicylate products have also been associated with alterations in maternal and neonatal hemostasis mechanisms, decreased birth weight, and with perinatal morta ...
TRETN MEDICINES INFORMATION CENTRE
TRETN MEDICINES INFORMATION CENTRE

... the time each patch is applied is different – 7 days for Butrans® and 4 days for Transtec®. For amounts of buprenorphine delivered by the two brands of patch see table in detail aid, giving approximately equivalent doses of morphine. There is a lack of comparative studies with other opioid drugs suc ...
Discovering drug interactions: a text
Discovering drug interactions: a text

... ractions due to induction. A more common form is through transcription factors that regulate the drug-metabolizing enzymes. An alternative form is indirect induction through transcription factors. Such interaction occurs when drug A activates transcription factor TF, which regulates and induces enzy ...
3.2 Genetics - Northwest ISD Moodle
3.2 Genetics - Northwest ISD Moodle

Advanced Animal Science Curriculum | Sam Houston State University
Advanced Animal Science Curriculum | Sam Houston State University

... Similarly, the allele frequency for "a" in this population is 0.5 (or 50%). B. Selection against the aa genotype We have just seen how two alleles of the same gene can be passed on if both genes have an equal chance of surviving. Now we will demonstrate what happens to allele frequency when there is ...
Evolution of Genetic Potential
Evolution of Genetic Potential

... [20]. Motivated by these observations, we model codon evolution at a single amino acid site under fluctuating selection for hydrophobicity. As in the first model, natural selection produces three distinct outcomes with increasing environmental variability. Each outcome corresponds to distinct expectat ...
Established and forthcoming drugs for the treatment of osteoporosis
Established and forthcoming drugs for the treatment of osteoporosis

... osteoporotic vertebral fracture at the beginning of the study, were included.21 New vertebral fractures occurred in 14% of the women in the placebo group and in 5% and 4%, respectively, of the women in the 20 mg and 40 mg PTH 1-34 groups; the respective relative risks, as compared with the placebo g ...
Up in Smoke - Marijuana Today - Burns M. Brady
Up in Smoke - Marijuana Today - Burns M. Brady

... At its approval, these statements become the official policy of the Society. April meeting, the ASAM Board of Directors approved four Public Policy Statements at the recommendation of the Public Policy committee, chaired by Sheila Blume, MD. With the board’s The Public Policy Statement on Marijuana, ...
Mendelian Genetics notes
Mendelian Genetics notes

... Two organisms, with genotypes BbDD and BBDd are mated. Assuming independent assortment of the B/b and D/d genes, write the genotypes of all possible offspring from this cross and use the rules of probability to calculate the chance of ...
P-Glycoprotein in the Blood-Brain Barrier of Mice Influences the
P-Glycoprotein in the Blood-Brain Barrier of Mice Influences the

... Whereas humans have only one drug-transporting P-GP (MDR1), mice have two, mdr1a (also called mdr3) and mdr1b (also called mdr1) (2, 6, 7). The tissue distribution of these proteins suggests that the two mouse isoforms together perform the same function(s) as the single human MDR1 protein (8–12). We ...
2015 DRUGS TO WATCH
2015 DRUGS TO WATCH

... fraction in the fourth quarter of 2014, with approval decisions anticipated in late 2015. In November 2014, the drug was granted European Accelerated Assessment, which will significantly shorten the EU review process. Filing was based on data from the PARADIGM-HF trial of LCZ-696 versus enalapril, w ...
Simultaneous detection of alpha-thalassemia and beta
Simultaneous detection of alpha-thalassemia and beta

... Thalassemia is most common genetic disorder in Asia. The approach to dealing with the problem of thalassemia is to prevent and control the birth of new cases. This requires an accurate identification of couples at high risk of thalassemia. A previous study has shown that microarrays can be used to d ...
Epidermal Growth Factor Receptor and K
Epidermal Growth Factor Receptor and K

...  Only 2 patients found to have EGFR mutations  3 patients without EGFR mutations responded to treatment  But 4/23 patients prevented from unnecessary treatment  Given that erlotinib is effective in only 10-20% of NSCLC patients selection ...
pH TRIGGERED DRUG DELIVERY OF ORNIDAZOLE FROM EUDRAGIT COATED CHITOSAN MICROSPHERE:
pH TRIGGERED DRUG DELIVERY OF ORNIDAZOLE FROM EUDRAGIT COATED CHITOSAN MICROSPHERE:

... methacrylate etc. The idea behind Microspheres forColon specific drug delivery system is intended because it may reduce the Systemic side effect because of low dose of the drug. The absorption of the poorly absorbed drug is increase because of increase retention time in the colon1, 2. Ornidazole is ...
1 Solu-Medrol® methylprednisolone sodium
1 Solu-Medrol® methylprednisolone sodium

... succinate, and may be unrelated to the speed or duration of infusion. Persons who are on drugs which suppress the immune system are more susceptible to infections than healthy individuals. Chicken pox and measles, for example, can have a more serious or even fatal course in non-immune children or ad ...
erlotinib - Cancer Care Ontario
erlotinib - Cancer Care Ontario

... Mutation status must be confirmed prior to starting erlotinib; in the pivotal trial only patients with exon 19 deletions and exon 21 L858R point mutation were included- limited evidence regarding efficacy with other EGFR mutations. ...
Kisqali - Novartis Pharmaceuticals Corporation
Kisqali - Novartis Pharmaceuticals Corporation

... of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety data reported below are based on Study 1 (MONALEESA-2), a clinical study of 668 postmenopausal women receiving KISQALI plus letrozole or placebo plus l ...
Mendel`s Law
Mendel`s Law

... recessive. Determine if the trait is autosomal dominant or recessive. Try the following designations: A = the trait (a genetic disease or abnormality, dominant) a = normal (recessive) a) Assign a genotype to each individual. If more than one genotype is possible, write both. ...
Quick Overview of Bioinformatics - What's New?
Quick Overview of Bioinformatics - What's New?

... B. Bloom (1995) A microbial minimalist. Nature 378:236 ...
Revisiting the Isobole and Related Quantitative Methods for
Revisiting the Isobole and Related Quantitative Methods for

... Loewe (1927, 1928, 1953), it is a graph in Cartesian coordinates in which the axes are the doses of the respective drugs. These are drugs or compounds that produce overtly similar effects (e.g., two analgesics, two antihypertensives, etc.) The graph consists of a line (or a curve) that represents do ...
Injection and Infusion Billing and Coding - min
Injection and Infusion Billing and Coding - min

... Chemotherapy and other highly complex drug administration Chemotherapy and other complex drug administration services are typically more complicated than injection and infusion services. These services generally require more monitoring (e.g., blood pressure), and the risk of adverse patient reaction ...
Obsessive-Compulsive Disorder: An Overview for
Obsessive-Compulsive Disorder: An Overview for

... (1) repetitive behaviors (e.g., hand washing, ordering, checking) or mental acts (e.g., praying, counting, repeating words silently) that the person feels driven to perform in response to an obsession, or according to rules that must be applied rigidly (2) the behaviors or mental acts are aimed at ...
< 1 ... 453 454 455 456 457 458 459 460 461 ... 1254 >

Pharmacogenomics

Pharmacogenomics (a portmanteau of pharmacology and genomics) is the study of the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Through the utilization of pharmacogenomics, it is hoped that drug treatments can deviate from what is dubbed as the “one-dose-fits-all” approach. It attempts to eliminate the trial-and-error method of prescribing, allowing physicians to take into consideration their patient’s genes, the functionality of these genes, and how this may affect the efficacy of the patient’s current and/or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of ""personalized medicine""; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Whether used to explain a patient’s response or lack thereof to a treatment, or act as a predictive tool, it hopes to achieve better treatment outcomes, greater efficacy, minimization of the occurrence of drug toxicities and adverse drug reactions (ADRs). For patients who have lack of therapeutic response to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic-based recommendations for a given drug, two possible types of input can be used: genotyping or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report